Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sarepta Pursues DMD Gene Therapy Accelerated Approval To Be First To Market
New Data Analyses Swayed US FDA To Allow Early Filing
Jul 29 2022
•
By
Mandy Jackson
Sarepta hopes to fast-track SRP-9001 to DMD patients • Source: Shutterstock
More from Gene Therapies
More from Advanced Therapies